Lyme disease patients' serum contains IgM antibodies to Borrelia burgdorferi that cross‐react with neuronal antigens
- 1 September 1988
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 38 (9) , 1439
- https://doi.org/10.1212/wnl.38.9.1439
Abstract
Serum from patients with neurologic manifestations of Lyme disease had serum IgM antibodies that bound to normal human axons, whereas binding was absent or weak in patients without neurologic findings. Antiaxonal binding could be eliminated by absorption with Borrelia burgdorferi. A murine monoclonal antibody to the borrelial flagellin also bound to human axons.This publication has 7 references indexed in Scilit:
- INVIVO AND INVITRO EVIDENCE OF B-CELL HYPERACTIVITY DURING LYME-DISEASE1988
- Proliferative responses of mononuclear cells in Lyme disease. Reactivity to Borrelia burgdorferi antigens is greater in joint fluid than in bloodArthritis & Rheumatism, 1986
- A Borrelia-specific monoclonal antibody binds to a flagellar epitopeInfection and Immunity, 1986
- Chemical and Biologic Characterization of a Lipopolysaccharide Extracted From the Lyme Disease Spirochete (Borrelia burgdorferi)The Journal of Infectious Diseases, 1985
- The Spirochetal Etiology of Lyme DiseaseNew England Journal of Medicine, 1983
- Annals of Internal Medicine, 1977
- Characterization of self-reactive B cells by polyclonal B-cell activators.The Journal of Experimental Medicine, 1977